Disposition and Pharmacokinetics of a GalNAc3-Conjugated Antisense Oligonucleotide Targeting Human Lipoprotein (a) in Monkeys

Autor: Mark J. Graham, Rosie Z. Yu, Eric E. Swayze, Rudy Gunawan, Shannon Hall, Richard S. Geary, Jennifer Burkey, Noah Post, Scott P. Henry, Thomas A. Zanardi, Thazha P. Prakash, Punit P. Seth, Yanfeng Wang, Tae-Won Kim
Rok vydání: 2016
Předmět:
Zdroj: Nucleic acid therapeutics. 26(6)
ISSN: 2159-3345
Popis: Triantennary N-acetyl galactosamine (GalNAc3)-conjugated antisense oligonucleotides (ASOs) have greatly improved potency due to receptor-mediated uptake into hepatocyte. The disposition and pharmacokinetics of ISIS 681257, a GalNAc3-conjugated ASO, were studied in monkeys. Following subcutaneous (SC) injection, ISIS 681257 was rapidly absorbed into the systemic circulation, with peak plasma levels observed within hours after dosing. After reaching Cmax, plasma concentrations rapidly declined in a multiexponential manner and were characterized by a dominant initial rapid distribution phase in which drug transferred to tissues from circulation, followed by a much slower terminal elimination phase (half-life of 4 weeks). Intact ISIS 681257 is the major full-length oligonucleotide species in plasma (≥70%). In tissues, the conjugated-GalNAc sugar moiety was rapidly metabolized, leaving the fully unconjugated form as the only full-length oligonucleotide detected at 48 h after dosing. Unconjugated ISIS 681257 cl...
Databáze: OpenAIRE